Krsnaa Diagnostics Limited — PPTs, 26-10-2024: Investor Presentation

Krsnaa Diagnostics reported a strong Q2FY25, achieving 20% YoY revenue growth, 58% YoY increase in EBITDA, and an 87% rise in PAT, attributed to higher footfalls and improved efficiency. The company also announced a strategic investment in Apulki Healthcare, gaining exclusive diagnostics partnerships and long-term revenue visibility. Additionally, Krsnaa is expanding operations through new partnerships and a focus on underserved markets, reinforcing its position as India's leading diagnostic service provider.